Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 45.99B | 47.47B | 46.87B | 40.34B | 30.62B | 22.58B |
Gross Profit | 9.45B | 10.10B | 9.24B | 6.85B | 5.54B | 3.46B |
EBITDA | 6.47B | 7.42B | 6.68B | 4.81B | 3.14B | 2.52B |
Net Income | 2.18B | 2.80B | 2.45B | 1.14B | 457.00M | -123.00M |
Balance Sheet | ||||||
Total Assets | 66.45B | 65.55B | 61.70B | 58.26B | 55.12B | 42.77B |
Cash, Cash Equivalents and Short-Term Investments | 3.27B | 3.41B | 1.78B | 2.21B | 2.81B | 4.27B |
Total Debt | 0.00 | 9.43B | 21.70B | 21.13B | 18.20B | 12.30B |
Total Liabilities | 49.13B | 47.70B | 45.21B | 43.88B | 41.67B | 29.60B |
Stockholders Equity | 17.32B | 17.84B | 16.48B | 14.37B | 13.44B | 12.94B |
Cash Flow | ||||||
Free Cash Flow | -430.00M | -401.00M | 374.00M | -2.57B | -65.00M | 676.00M |
Operating Cash Flow | 2.49B | 2.34B | 2.58B | -660.00M | 1.53B | 1.99B |
Investing Cash Flow | -3.03B | -2.81B | -2.37B | -1.81B | -2.45B | -215.00M |
Financing Cash Flow | 1.05B | 1.39B | -128.00M | 2.22B | 1.17B | -1.87B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | €19.27B | 23.48 | 108.18% | 2.06% | 25.95% | 17.64% | |
72 Outperform | €13.96B | 6.41 | 12.80% | 6.28% | -2.98% | -14.55% | |
67 Neutral | €10.25B | 26.31 | 17.92% | 1.81% | 1.93% | 2.27% | |
66 Neutral | €20.34B | 8.61 | 13.10% | 7.09% | 19.74% | 208.29% | |
66 Neutral | €20.98B | 24.63 | 24.74% | 0.56% | 45.24% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | €28.14B | 11.57 | 11.21% | 5.38% | -6.83% | -32.20% |